Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adverum Biotechnologies

2.43
+0.21009.46%
Post-market: 2.450.0200+0.82%19:42 EDT
Volume:181.18K
Turnover:434.73K
Market Cap:50.76M
PE:-0.34
High:2.50
Open:2.25
Low:2.23
Close:2.22
Loading ...

Adverum Biotechnologies: Q4 Earnings Snapshot

Associated Press Finance
·
15 Apr

Adverum Biotechnologies Q4 EPS $(1.96) Misses $(1.38) Estimate

Benzinga
·
15 Apr

Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pipeline Highlights and Updates to Anticipated Milestones

THOMSON REUTERS
·
15 Apr

Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pipeline Highlights and Updates to Anticipated Milestones

GlobeNewswire
·
15 Apr

North American Morning Briefing: China Raises Tariffs on U.S. in Latest Salvo

Dow Jones
·
11 Apr

ADVISORY-Alert on Adverum Biotechnologies from press release by law firm withdrawn

Reuters
·
08 Apr

Investor Alert: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adverum Biotechnologies, Inc. - Advm

THOMSON REUTERS
·
08 Apr

U.S. RESEARCH ROUNDUP- BlackRock, Morgan Stanley, ServiceNow

Reuters
·
08 Apr

Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
05 Apr

North American Morning Briefing: Stock Futures Fall, Bonds Rally as Investors Negotiate Market Turmoil

Dow Jones
·
04 Apr

Major Shareholder Makes Bold Move in Adverum Biotechnologies!

TIPRANKS
·
03 Apr

Adverum Biotechnologies Inc expected to post a loss of $1.36 a share - Earnings Preview

Reuters
·
02 Apr

BRIEF-Adverum Biotechnologies Inc - Some Prior Financial Statements Should No Longer Be Relied Upon - SEC Filing

Reuters
·
01 Apr

Adverum Biotechnologies Inc - Some Prior Financial Statements Should No Longer Be Relied Upon - SEC Filing

THOMSON REUTERS
·
01 Apr

Adverum Biotechnologies Inc - Company Expects to Report at Least One Material Weakness - SEC Filing

THOMSON REUTERS
·
01 Apr

Adverum Biotechnologies Faces Subtenant Default Situation

TIPRANKS
·
01 Apr

Adverum Biotechnologies to Participate in the 2025 RBC Capital Markets Ophthalmology Virtual Conference

GlobeNewswire
·
01 Apr

Major Moves by Shareholder: Adverum Biotechnologies Stock in Focus

TIPRANKS
·
28 Mar

Adverum Biotechnologies Inc expected to post a loss of $1.36 a share - Earnings Preview

Reuters
·
26 Mar

North American Morning Briefing: Stock Futures Fall as Focus Shifts From Fed to Tariffs

Dow Jones
·
21 Mar